Answers are grounded in this paper and cite their sources.
This narrative explores the definition of standard of care in neurosurgery, highlighting innovation challenges and the role of literature.
As an author and an editor, one cannot escape the power of the document. Everything we do depends on it. The written scholarly report provides the justification for what we do every day as neurosurgeons, makes us evolve when we are convinced about something new or better, and is the singular statement that contributes bit by bit to the greater good. Or so we hope. I have long been troubled by the concept of “standard of care.” It has so many elements to it. When does something become standard or widely accepted? Who decides this? It often serves as the brakes on a system, the “handcuffs,” that limit innovation. Academic surgeons are charged to innovate, to think differently, to collect data, and to share those findings, most of which are beyond “standard of care.” Neurosurgery has multiple brakes: the patients (who may not want what we are offering), ourselves (who sometimes disagree with each other), the medicolegal practitioners, and payers. Payers like to hide behind “standard of care” when they choose to deny payment for what we are doing next. In the past, such denials were commonly made by nonneurosurgeon physicians or nurses, often retired or outside actual clinical practice. Now, increasingly it is an artificial intelligence system making nonintelligent decisions that to a patient or family are hardly artificial. This recently happened to me and despite a strongly crafted letter “to the top” of a major insurance carrier, with the medical evidence to back my argument, I received no response. Did I really expect one? So perhaps a different question is “what decides standard of care?” It really comes down to what has been published. Is the procedure “established?” If so, is it time honored? How much time does it take to become time honored or, better yet, insurance payer honored? That would be a new thought. Most of us deal with this problem on a regular basis. The problem of some random person who may or not be a physician, usually not a neurosurgeon, usually not even in clinical practice, weighing on what I had proposed to do for a patient. The classic example in my own field related to performing stereotactic radiosurgery for multiple brain metastases. A patient may have 6 or 7 brain metastases, be asymptomatic and hoping to remain so. Yet, some insurance company would say “no” because randomized trial data for radiosurgery vs whole brain radiotherapy only studied patients with 2-4 tumors (not more than 4). Well, that was all good, glad they read the literature. And then I had to get on the phone and talk to the decision maker. The irony was that I was the person who did that randomized trial, so they clearly respected my prior work. They just did not respect my current work! When I would tell them where the upper limit of 4 tumors came from (which of course they did not know), I would tell them that it was just a random number that I simply chose. I guess I should have chosen 7. It was not until a later Japanese study showed that 5-10 tumors had similar outcomes to 2-4 that the community moved past counting tumors, to evaluating total tumor volumes (ie, the actual cancer burden). So that was their use of literature, my own literature, to define a “standard of care” that I did not agree with. I was puzzled by this paradox. Franz Kafka comes to mind. About 10 years ago, my then student Zane Schnurman, now a fellow at Stanford, tackled the problem of standard of care. We hypothesized that it was the scientific literature alone that decides. Certainly, a medical concept with no published backing would be considered “not standard.” Or should it? The classic example often touted is that one does not need a scientific study to show that using a parachute when jumping out of an airplane would be a good decision—widely accepted as “standard.”1 In our work, we showed that there really are only two kinds of scientific clinical research reports. The first type is the initial reports about a concept. These show the value of the idea. Often many investigators show the same thing, and prove reproducibility. Aneurysms can be coiled instead of clipped. The second type is the refining reports about the concept. Yes, aneurysms can be coiled, but if done “this way,” or “that way,” or as one example, with balloon support, then the surgery is refined. Only someone who accepts the first idea as reasonable would try to refine it. Then, when the number of annual refining articles passes the number of initial articles on a topic, that is the point when standard of care has been reached. At that point, the scholarly community has accepted the concept, and almost all future work will be on its improvement. It has now been considered accepted and worthy. We called this approach progressive scholarly acceptance.2 In reality, it did not take long before coiling aneurysms became standard. We also showed that the pace toward acceptance is based on two things: having enough clinical data to study and being suitable for randomization. Our path to the continued refinement of neurosurgery begins with understanding what we do and its current literature-based foundations, bringing forth our new ideas and innovations, proving their value through research, gaining acceptance through the peer-reviewed literature, and letting all those other folks follow along. But if we want them to follow promptly, we have to start typing. Douglas Kondziolka, MD, MSc Editor-in-Chief, Neurosurgery Publications New York, New York, USA
No takes yet. Share an insight, caveat, or question.
Douglas Kondziolka (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: